Skip to main content
. 2021 Nov;62(11):1537–1544. doi: 10.2967/jnumed.120.251173

FIGURE 4.

FIGURE 4.

Ex vivo biodistribution and tumor uptake of 111In-GFP-G1-TAT. (A) Ex vivo biodistribution showing uptake of 111In-GFP-G1-TAT in selected tissues and blood, 72 h after intravenous administration. (B) Tumor uptake of 111In-GFP-G1-TAT correlating linearly in vivo with expression of H2B-EGFP. Asterisks denote statistically significant differences in uptake from H1299 WT group. *P < 0.05. **P < 0.01.